In NAFLD, IL-6 may enhance hepatic repair and regeneration; however, IL-6 may also promote insulin resistance and hepatocyte apoptosis, thus contributing to NASH development [48, 50]. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatotic liver disease.